MIKHAIL ALPER: Open Payments
NPI 1588698112 · MADERA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286,377 in 786 payments from 24 companies in 2025. Trend: 2023 $183,337 · 2024 $265,602 · 2025 $286,377
Speaker / faculty: $211,981Travel & lodging: $40,997Food & beverage: $17,639Consulting: $12,430Honoraria: $3,200Education: $130
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 124 | $77,600 |
| ABBVIE INC. | 135 | $41,799 |
| Aimmune Therapeutics, Inc. | 77 | $27,489 |
| Madrigal Pharmaceuticals | 66 | $24,852 |
| Gilead Sciences, Inc. | 51 | $23,083 |
| Regeneron Healthcare Solutions, Inc. | 42 | $21,723 |
| Lilly USA, LLC | 23 | $15,687 |
| GENZYME CORPORATION | 20 | $14,689 |
| Ipsen Biopharmaceuticals, Inc | 32 | $11,526 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 99 | $6,922 |
Products named: TREMFYA, ZENPEP, REZDIFFRA, Livdelzi, CREON, DUPIXENT, OMVOH, IQIRVO.
Industry payments across CA — which companies pay providers there.
